The number of people with susceptibility test result for rifampicin in Czechia
Czechia: The number of people with susceptibility test result for rifampicin was 239 in 2021. ▼ Falling
Latest (2021)
239
Change on year
up 7.2%
World rank
90th
of 155 countries
All-time high
308
in 2019
All-time low
223
in 2020
Years of data
5
2017–2021
The number of people with susceptibility test result for rifampicin in Czechia, 2017–2021
Source: World Health Organization, Global Health Observatory.
Analysis
In 2021, the number of people with susceptibility test result for rifampicin in Czechia stood at 239.
That represents a change of up 7.2% on the previous year and down 19.3% over five years.
That places Czechia 90th out of 155 countries with data for 2021, putting it in the middle of the range.
The number of people with susceptibility test result for rifampicin in Czechia, year by year
| Year | Value | Change |
|---|---|---|
| 2017 | 296 | — |
| 2018 | 278 | -6.1% |
| 2019 | 308 | +10.8% |
| 2020 | 223 | -27.6% |
| 2021 | 239 | +7.2% |
Czechia compared with similar countries
- Czechia's 239 is above the median for high income countries, which is 142, 1.7× the median. (61 countries reporting)
- Czechia's 239 is above the median for Europe & Central Asia, which is 229.5, 1.0× the median. (44 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 294 | 278 | 308 | 3 |
| 2020s | 231 | 223 | 239 | 2 |
Countries ranked near Czechia
- 87 El Salvador 316 compare
- 88 Netherlands 270 compare
- 89 Bosnia and Herzegovina 255 compare
- 91 Lebanon 228 compare
- 92 Switzerland 220 compare
- 93 Armenia 209 compare
More health data for Czechia
- Un projection of annual infant deaths, annual growth rate 0 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.7726 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,169 deaths per 1,000 people (2090)
- Number of infants who die before age 1 34 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -5.76 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0222 units per person (2025)
- Population ages 00-04, male, annual growth rate -5.46 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is the number of people with susceptibility test result for rifampicin in Czechia?
- The number of people with susceptibility test result for rifampicin in Czechia was 239 in 2021, according to World Health Organization, Global Health Observatory.
- What is the highest the number of people with susceptibility test result for rifampicin recorded in Czechia?
- The highest recorded value was 308 in 2019.
- What is the lowest the number of people with susceptibility test result for rifampicin recorded in Czechia?
- The lowest recorded value was 223 in 2020.
- How does Czechia rank for the number of people with susceptibility test result for rifampicin?
- Czechia ranks 90th out of 155 countries with data for 2021.
- Where does this Czechia data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).